Please use this identifier to cite or link to this item: http://10.1.7.192:80/jspui/handle/123456789/6185
Full metadata record
DC FieldValueLanguage
dc.contributor.authorPatel, Bhumi N.-
dc.date.accessioned2015-09-22T08:04:13Z-
dc.date.available2015-09-22T08:04:13Z-
dc.date.issued2015-
dc.identifier.urihttp://hdl.handle.net/123456789/6185-
dc.description.abstractAsia is world’s largest and most populated continent having huge diversity in culture, climate, and government system. Nowadays Asian countries are progressively tightening their healthcare regulation standards. For the successful drug registration in Asia region,local knowledge of healthcare regulations plays vital role for improving the speed, cost and efficiency of introducing new medicines into these markets, thereby allowing timely access to patients. In this dissertation I have described various healthcare regulatory authorities, their registration requirements including types of application, registration fees, approval timeline, stability data requirements and requirements for change in registration of product particulars. Regulatory aspects of these countries are developing and changing constantly. Hence, regulatory professionals need to be updated with the current regulations.en_US
dc.publisherInstitute of Pharmacy, Nirma University, A'baden_US
dc.relation.ispartofseriesPDR00355-
dc.subjectDissertation Reporten_US
dc.subjectPharmaceutical Analysisen_US
dc.subject13MPHen_US
dc.subject13MPH801en_US
dc.subjectPDR00355en_US
dc.titleRegistration Requirements of Medicinal Products for Human Use in Asia: An Emerging Pharmaceutical Marketen_US
dc.typeDissertationen_US
Appears in Collections:M.Pharm. Research Reports, Pharmaceutical Analysis

Files in This Item:
File Description SizeFormat 
PDR00355.pdfPDR003554.7 MBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.